Effects of Lubiprostone on Gastric Function in Patients With Chronic

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02361749` - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation	Phase 4
Terminated	`NCT02239510` - Efficacy of Linaclotide to Senna for CIC	N/A
Completed	`NCT01895543` - Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT02291679` - Trial of Linaclotide in Patients With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01989234` - A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation	Phase 2
Completed	`NCT01993875` - Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01674530` - Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01429987` - The Plecanatide Chronic Idiopathic Constipation (CIC) Study	Phase 2/Phase 3
Completed	`NCT01982240` - 12-Week Study of Plecanatide for CIC (The CIC3 Study)	Phase 3
Completed	`NCT02590432` - An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation	Phase 4
Completed	`NCT02481947` - A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults	Phase 3
Completed	`NCT01372423` - Evaluation of Clinical Equivalence Between Two Lubiprostone Products	Phase 3
Completed	`NCT03054506` - The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation	N/A
Recruiting	`NCT04804267` - Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation	Phase 3
Completed	`NCT03879239` - Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation	N/A
Completed	`NCT01053962` - SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation	Phase 2
Completed	`NCT03097861` - Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo	Phase 3
Completed	`NCT03551873` - A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
Completed	`NCT02819310` - An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults	Phase 3
Completed	`NCT02819297` - BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults	Phase 3

NCT number	NCT01460225
Study type	Interventional
Source	Dartmouth-Hitchcock Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	September 2007
Completion date	January 2011

Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms